Clinical Trials at Other Local Research Sites
The Harvard/Boston Medical Center/Miriam Hospital AIDS Clinical Trials Unit (CTU) comprises a consortium of five Clinical Research Sites (CRS) located at Massachusetts General Hospital (MGH), Brigham and Women’s Hospital (BWH), Beth Israel-Deaconess Medical Center (BIDMC), Boston Medical Center (BMC) and the Miriam Hospital in Providence, Rhode Island. Each of the five CRSs is affiliated with the national AIDS Clinical Trials Group (ACTG) and throughout its 26-year history investigators of this CTU have made major contributions to therapeutic research in AIDS and have played a critical role in the scientific leadership of the ACTG.
As the principal investigator of the CTU, Dr. Daniel Kuritzkes oversees all scientific, clinical, laboratory and administrative aspects of the CTU and its component CRSs. Dr. Kuritzkes is a Professor of Medicine at Harvard Medical School and Chief of Infectious Diseases at BWH. Dr. Kuritzkes is also Chair of the national AIDS Clinical Trials Group.
A principal strength of the Harvard/BMC/Miriam Hospital CTU is the outstanding group of investigators and study staff located at each of the five CRSs- who are experienced, productive and well-respected leaders in HIV clinical research.
How can I learn more about Clinical Trials at other local Research Sites?
To learn more contact the CRS Study Coordinator at:
Beth Israel-Deaconess Medical Center:
Andrea Kershaw, ANP: 617-632-7627
Boston Medical Center:
Betsy Adams, RN 617-414-7082
Brigham and Women’s Hospital:
Cheryl Keenan, RN: 617-732-5635
Miriam Hospital, Providence, RI :
Pam Poethke, RN 401-793-4971